Home / Going-concern warnings / Silo Pharma, Inc.
Filed 2025-11-13 路 Form 10-Q 路 Accession 0001213900-25-110006 nano
Price before filing: $6.77 (2025-11-12 close, split/dividend-adjusted)
Market cap at flag: $5.8M (2025-11-13) 路 Latest: $1.3M (2026-10-16)
| Window | SILO | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -10.8% | -0.4% | -10.4% | 2025-12-15 |
| 90 days | -35.6% | +1.6% | -37.2% | 2026-02-11 |
| 180 days | -12.3% | +8.6% | -20.9% | 2026-05-12 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: no open-market insider sales or purchases reported.
30 days after: 1 insider bought $6K (4 purchases)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-11-13: red flag filed | |||||||
| 2025-11-18 | Weisblum Eric Chief Executive Officer, Director | Purchase | 7,500 | $0.40 | $3K | no | Form 4 |
| 2025-11-19 | Weisblum Eric Chief Executive Officer, Director | Purchase | 4,500 | $0.41 | $2K | no | Form 4 |
| 2025-11-20 | Weisblum Eric Chief Executive Officer, Director | Purchase | 1,000 | $0.37 | $370 | no | Form 4 |
| 2025-11-21 | Weisblum Eric Chief Executive Officer, Director | Purchase | 1,000 | $0.36 | $365 | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-08-15 to 2025-12-13. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"As of September 30, 2025, the Company had cash and cash equivalents of $ 3,917,627 , short-term investments of $ 1,948,579 , and working capital of $ 5,456,030 . The positive working capital serves to mitigate the conditions that historically raised substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-09-30)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.